The B.C. NDP government’s handling of a costly treatment for a rare disease in a 10-year-old girl has put the spotlight on a ...

Obstetricians and psychiatrists are concerned about a recent FDA panel spreading misinformation about the potential harms of using SSRIs during pregnancy and postpartum.

The Central Drugs Standard Control Organisation (CDSCO) has directed all state and union territory drug regulators to ensure ...

Food and Drug Administration Commissioner Marty Makary has taken a personal interest in addressing hormone therapy treatment for menopause.

Food dyes are known to have a wide range of impacts on health, such as cancer risks, behavioral problems in children, and ...

A key House committee is looking into the investigation of the late Jeffrey Epstein for sex trafficking crimes, working to ...

Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...

The FDA may remove the warning labels on hormone replacement therapies used to treat the symptoms of menopause. Doctors say ...

The FDA may remove the warning labels on hormone replacement therapies used to treat the symptoms of menopause. Doctors say ...

Eli Lilly and Co. won the backing of European Union regulators for its Alzheimer’s disease drug Kisunla in a specific group ...

On Nov. 26, 2019, ChemoCentryx issued a press release announcing that the Advocate trial met both of its primary endpoints, saying Tavneos showed noninferiority of disease remission at 26 weeks and ...

Elevidys shipments paused following third death; FDA committee votes against brexpiprazole combo for PTSD; Rapiblyk now available for SVT; sleep apnea pill looks promising; JUUL e-cigarettes gain ...